еНаука - преглед
Преглед према Аутор Wolf, Dominik
Приказ резултата 1 до 5 од 5
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2008 | CELSG CML 11 "ISTAHIT" Phase III Study - Planned Interim Analysis: High Doses of Imatinib Mesylate (800mg/day) Significantly Improve Rates of Major and Complete Cytogenetic Remissions (MCR, CCR) in Pretreated Ph+/BCR-ABL(+) CML Patients in Chronic Phase | Petzer, Andreas L.; Wolf, Dominik; Fong, Dominic; Bošković, Darinka; Ulmer, Hanno; Gastl, Guenther | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2019 | JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms (✓) | Rao, Tata Nageswara; Hansen, Nils; Hilfiker, Julian; Rai, Shivam; Majewska, Julia-Magdalena; Leković, Danijela   ; Gezer, Deniz; Andina, Nicola; Galli, Serena; Cassel, Teresa;
Geier, Florian; Delezie, Julien; Nienhold, Ronny; Hao-Shen, Hui; Beisel, Christian; Di Palma, Serena; Dimeloe, Sarah; Trebicka, Jonel; Wolf, Dominik; Gassmann, Max; Fan, Teresa W. -M.; Lane, Andrew N.; Handschin, Christoph; Dirnhofer, Stefan; Kroeger, Nicolaus; Hess, Christoph; Radimerski, Thomas; Koschmieder, Steffen; Čokić, Vladan
; Skoda, Radek C.; | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2023 | Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry (✓) | Salmanton-García, Jon; Marchesi, Francesco; Koehler, Philipp; Weinbergerová, Barbora; Čolović, Nataša ; Falces-Romero, Iker; Buquicchio, Caterina; Farina, Francesca; van Praet, Jens; Biernat, Monika M.;
Itri, Federico; Prezioso, Lucia; Tascini, Carlo; Vena, Antonio; Romano, Alessandra; Delia, Mario; Dávila-Valls, Julio; Martín-Pérez, Sonia; Lavilla-Rubira, Esperanza; Adžić-Vukičević, Tatjana
; García-Bordallo, Daniel; López-García, Alberto; Criscuolo, Mariana; Petzer, Verena; Fracchiolla, Nicola S.; Espigado, Ildefonso; Sili, Uluhan; Meers, Stef; Erben, Nurettin; Cattaneo, Chiara; Tragiannidis, Athanasios; Gavriilaki, Eleni; Schönlein, Martin; Mitrović, Mirjana ; Pantić, Nikola ; Merelli, Maria; Labrador, Jorge; Hernández-Rivas, José-Ángel; Glenthøj, Andreas; Fouquet, Guillemette; del Principe, Maria Ilaria; Dargenio, Michelina; Calbacho, María; Besson, Caroline; Kohn, Milena; Gräfe, Stefanie; Hersby, Ditte Stampe; Arellano, Elena; Çolak, Gökçe Melis; Wolf, Dominik; Marchetti, Monia; Nordlander, Anna; Blennow, Ola; Cordoba, Raul; Mišković, Bojana; Mladenović, Miloš; Bavastro, Martina; Limongelli, Alessandro; Rahimli, Laman; Pagano, Livio; Cornely, Oliver A.; | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2007 | Multicenter, randomized, phase III study comparing imatinib (Glivec) standard dose (400 mg/d) with imatinib high dose induction (800 mg/d) followed by imatinib maintenance (400 mg/d) in patients with pretreated Ph+/BCR-ABL(+) CML in chronic phase - Result | Petzer, Andreas L; Wolf, Dominik; Fong, Dominic; Lion, Thomas; Dyagil, Irina; Masliak, Zvenyslava; Boskovic, Darinka V; Griskevicius, Laimonas; Lejniece, Sandra; Spasov, Emil;
Gercheva, Liana; Stojanovic, Aleksandar; Peytchev, Dontcho; Tzvetkov, Nikolay; Griniute, Rasa; Stanchev, Atanas; Kwakkelstein, Martin; Ulmer, Hanno; Gastl, Guenther A;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2011 | Pre-treated CML Patients in chronic phase (CP) not achieving at least a major cytogenetic remission (MCyR) after imatinib high dose (HD) induction (800 mg/day, 6 months) are at high risk of progression after dose reduction - Sub-analyses from the CELSG ph | Petzer, Andreas L; Fong, Dominic; Lion, Thomas; Dyagil, Irina; Masliak, Zvenyslava; Bogdanovic, Andrija D ; Griskevicius, Laimonas; Lejniece, Sandra; Goranov, Stefan; Gercheva, Liana;
Stojanovic, Aleksandar; Peytchev, Dontcho; Tzvetkov, Nikolay; Griniute, Rasa; Oucheva, Radka; Grubinger, T; Kwakkelstein, Marthin; Rancati, Francesca; Gastl, Guenther A; Wolf, Dominik;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |